Asset Valuation Services
Understanding the true value of your product or services can make a difference when it comes to strategic planning, investment, and partnership discussions. We provide data-based valuations of drugs, devices & royalties.
Services
Pipeline and Technology Valuation: rNPV, Monte Carlo, comparable-transaction comps for drugs, devices, diagnostics, digital health.
Market Opportunity Analysis: TAM/SAM forecasting, adoption curves, competitive intensity scoring.
Royalty and Licensing Valuation: DCF of future streams, milestone waterfall modelling.
Strategic Valuation Advisory: Scenario analysis for M&A, spin-outs, Series A-D rounds.
Need Some Help?
Feel free to contact us for any inquiry or book a free consultation.
